MUSTI.HEMUSTI.HEHEL
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.62% | +11.76% | +16.99% | +14.18% | +14.61% |
| Gross Profit Growth | -3.02% | +59.93% | +93.41% | +11.27% | -29.04% |
| EBITDA Growth | -15.74% | +151.39% | +140.41% | -8.98% | +8.60% |
| Operating Income Growth | -52.62% | +0.00% | -84.59% | -56.37% | +5.54% |
| Net Income Growth | -51.41% | +0.00% | +0.00% | -92.14% | -83.22% |
| EPS Growth | -50.06% | +0.00% | +0.00% | -92.12% | -83.27% |
| EPS Diluted Growth | -50.18% | +0.00% | +0.00% | -92.07% | -83.23% |
| Weighted Average Shares Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Diluted Growth | -0.30% | +0.30% | -0.30% | -0.30% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | -234.62% |
| Operating Cash Flow Growth | -51.85% | +198.09% | +0.00% | -34.04% | +174.95% |
| Free Cash Flow Growth | -76.25% | +434.19% | +0.00% | -47.84% | +448.56% |
| Receivables Growth | -7.38% | -29.20% | +0.00% | -26.81% | +28.92% |
| Inventory Growth | +13.68% | +25.60% | +16.99% | +13.63% | +17.10% |
| Asset Growth | +11.38% | +14.18% | +12.09% | +9.28% | +11.19% |
| Book Value per Share Growth | -2.62% | +5.02% | +2.31% | +0.74% | +1.36% |
| Debt Growth | +28.24% | +26.64% | +18.91% | +15.73% | +12.83% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +33.01% | -31.52% | +0.00% | -100.00% | -100.00% |